Zentiva ks specializes in the development, manufacture and marketing of generic pharmaceutical products. It offers generic drugs, over the counter medicines, dietary supplements, cosmetics and pharmaceutical substances. The company's products cover therapy areas of cardiovascular disease, pain, alimentary, genitourinary tract diseases, inflammations and central nervous system diseases including digestive problems. Zentiva was founded in 1989 and is headquartered in Prague, Czech Republic.

Part of Novartis AG, Sandoz AG is a Swiss company located in Basel. The firm develops generic medicines and biosimilars.

Dr. Reddy's Laboratories Ltd. engages in the manufacture and marketing of pharmaceutical products. It operates through the following segments: Global Generics, Pharmaceutical Services & Active Ingredients, Proprietary Products, and Others. The Global Generics segment consists of manufacturing and marketing of prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name or as generic finished dosages with therapeutic equivalence to branded formulations. The Pharmaceutical Services & Active Ingredients segment is comprised of manufacturing and marketing of active pharmaceutical ingredients and intermediates, also known as API, which are the principal ingredients for finished pharmaceutical products. The Proprietary Products segment focuses on research and development of differentiated formulations. The Others segment includes the operations of the subsidiary of the company. The company was founded by Kallam Anji Reddy on February 24, 1984 and is headquartered in Hyderabad, India.

Established in 1973 in Korea, Hanmi Pharmaceuticals now is one of the top 5 pharmaceutical companies in terms of revenue, and the most R&D focused company with the highest R&D investment for several years. Hanmi has been successful for a few decades with high flexibility, continuously changing its market/development strategy from first generics to IMD & FDC (Incrementally Modified Drug and Fixed Dose Combination) to new drug development including innovative small molecules and biologics. During the period of significant changes, Hanmi made multiple strategic collaboration relationships with multinational companies and biotech companies. Based on the success in 1980s and 1990s, Hanmi started its Chinese operation in 1996 with establishment of Beijing Hanmi. Now, Beijing Hanmi grew as a well-localized and well-settled Chinese company with more than 1,300 staffs including R&D, sales / marketing, and manufacturing experts and significant growth rate higher than 20% every year. Currently, Hanmi and Beijing Hanmi is closely collaborating on various business opportunities and new drug development projects as well as sales and marketing in Chinese territories. As the only Asian company with significant presence both in Korea and China, as the most R&D focused company with number of clinical stage projects with competitiveness, and as the company with open innovation based on multiple development/marketing collaborations, Hanmi is trying to develop and provide differentiated treatment options to patients suffering from various disease.

Since its establishment in 2000, Lixin Pharmaceutical has adhered to the goal of making globally regulated APIs and important intermediates to dominate the market, and has continued to rely on technological innovation to drive the company and follow the path of sustainable development, gradually forming anti-tumor, cardiovascular, anti-platelet and treatment. The API system in the field of Alzheimer's disease has become a quality supplier to many pharmaceutical companies around the world, and has established long-term cooperative relationships with many famous domestic and foreign pharmaceutical companies to achieve win-win cooperation. 　　Lixin Pharmaceutical focuses on the in-depth research, development and production of specialty raw materials and major diseases, and adheres to the scientific, rigorous and standardized corporate culture, advocating the spirit of innovation, focusing on safety, environmental protection, low consumption and high quality original technology. The development and application of the company has more than 30 international invention patents in China, the United States, Europe and other regions, and has formed an independent independent intellectual property system. Lixin Pharmaceutical not only provides high-quality raw materials and key intermediates, but also provides integrated technical solutions including raw material process development, quality research, crystal and particle size research, and standard and impurity reference products according to customer needs. . The company has obtained 3 US DMF documents, 3 CEP certificates, 5 CFDA new drug certificates and 8 domestic GMP certificates. At the same time, more than 20 products are being established, R&D and domestic and foreign registration. It has laid a solid foundation for the company's rapid and efficient sustainable development.

Beijing Xinkaiyuan Pharmaceutical Technology Co., Ltd., established on 2014-03-20, Business scope includes biotechnology promotion;Medical Research;technology development;technical consulting;technology transfer;Import and export,Technology Import and Export,Agent import and export.(Enterprises independently choose operating projects according to law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policy of the district.)

Wante Pharmaceutical (Hainan) Co., Ltd., established on 2004-03-09, Business scope includes licensed projects:pharmaceutical production;Drug Wholesale(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)General project:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Chemical product sales(No licensed chemical products)(Except for licensed business,Can independently operate projects that are not prohibited or restricted by laws and regulations)

Alvogen Korea Co., Ltd. engages in the manufacture of pharmaceutical products. It offers products for the therapeutic areas of endocrine system, urinary system, neuropsychiatry system, anti-inflammatory, antipyretic, analgesic, gastrointestinal system, cardiovascular system, dermatology, hepatitis, antibiotics, respiratory system, hormones etc. It provides pharmaceutical products in various dosage forms, including tablets, capsules, granules, powders, ampoules, vials and intravenous (IV) solutions. The company was founded on January 7, 1958 and is headquartered in Seoul, South Korea.

Erregierre SpA manufactures and supplies ingredients for pharmaceutical use. Its services include knoevenagel, aldol reaction, malonic, hantzsch synthesis, diazotizations, nitrations, oxidations and halogenations. The company was founded in 1974 and is headquartered in San Paolo d'Argon, Italy.

Divi’s is engaged in manufacturing leading generic compounds, nutraceutical ingredients and custom synthesis of APIs and intermediates for global innovator companies primarily for export to regulated markets such as US and Europe. With two manufacturing facilities, market presence across several countries and a team of 10,000 employees, Divi’s continues to innovate to bring robust techniques to facilitating sustainable manufacturing processes.

KYONGBO PHARMACEUTICAL Co., Ltd. engages in the manufacture and sale of pharmaceutical products. Its products include general, antibiotic, and anticancer active pharmaceutical ingredients, inhalation anesthetics, cefaclor capsules, and cefaclor dried syrups. The company was founded on March 31, 1987 and is headquartered in Asan-si, South Korea.

Mirae Fine Chemical is a pharmaceutical company with a focus on R&D, APIs, pharmaceutical intermediates, Pd catalysts, and custom production services. MFC is always concerned with product quality, and all of its products are manufactured in accordance with GMP standards. Independent QA & QC ensure the proper execution and operation of the GMP Quality system.

Nanjing Zhengji Pharmaceutical Sales Co., Ltd., established on 2007-12-03, Business scope includes licensed projects:Drug Wholesale;Drug retail;Drug import and export(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Import and export;Specialty Chemicals Sales(Free of Hazardous Chemicals);Food import and export;Technology Import and Export;Import and export agency;Chemical product sales(No licensed chemical products);Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Medical Research and Experimental Development;Sales of Class II Medical Devices;Medical Research and Experimental Development(remove human stem cells,Development and application of genetic diagnosis and treatment technology)(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Labworld Bio-Medicine Technology Corp. Ltd. engages in the pharmaceutical industry. Its services include research and development outsourcing services for pharmaceutical products, including technology transfer, technology development and technical services. The company was founded on November 6, 2003 and is headquartered in Beijing, China.

Jiangsu Zenji Pharmaceuticals Ltd. manufactures pharmaceutical products and its intermediates. Its products include medicine for the treatment stomach related issues using cimetidine. The company was founded on April 4, 2003 and is headquartered in Huai'an, China.

Tirsch (Nanjing) Drug Research and Development Co., Ltd., established on 2015-12-15, Business scope includes new drug research and development,Chemical synthesis and manufacturing of drug-related compounds;medicine,cosmetic,Development of detection technology in the field of agricultural products and environmental technology,technical consulting,Technical Services and Technology Transfer;Import and export of drug-related compounds,commission agent(outside the auction).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Sichuan Kelun Pharmacy Institute Co., Ltd., part of Sichuan Kelun Pharmaceutical Co., Ltd., is a company headquartered in Chengdu, China. The firm manufactures medicines. It was founded in 1998.

Jiangsu Yangtze River Pharmaceutical Group Co., Ltd. manufactures and distributes pharmaceutical products. It is a large cross-regional pharmaceutical group that features industry-university-institute cooperation and integrates scientific research, industrial production and sale. The company was founded in 1971 and is headquartered in Taizhou, China.